From: Clinical drug trials in general practice: a 10-year overview of protocols
Patients planned for inclusion | Clinical investigators | Payment | |||||
---|---|---|---|---|---|---|---|
Norway | All countries | Trial duration, weeks | General practicea | All sites in Norway | Investigators' payment per patient, €b | Estimated yearly income per investigator, €c | |
Median | 60 | 672.5 | 24 | 5 | 7 | 1,900 | 1,600 |
Minimum to maximum | 8 to 2,500 | 8 to 31,000 | 1 to 288 | 1 to 402 | 1 to 402 | 0 to 13,500 | 0 to 59,000 |
2.5 to 97.5 percentile | 13 to 560 | 50 to 14,368 | 3 to 240 | 1 to 37 | 1 to 61 | 0 to 7,500 | 0 to 25,000 |
Sum | 23,635 | 337,921 | 1,920 | 2,475 |